PT Phapros, Tbk (PEHA.JK)

IDR 272.0

(-2.86%)

Operating Expenses Summary of PT Phapros, Tbk

PT Phapros, Tbk's latest annual operating expenses in 2023 was 428.44 Billion IDR , down -4.63% from previous year.
PT Phapros, Tbk's latest quarterly operating expenses in 2024 Q2 was 103.57 Billion IDR , up 12.39% from previous quarter.
PT Phapros, Tbk reported a annual operating expenses of 489.78 Billion IDR in annual operating expenses 2022, up 14.05% from previous year.
PT Phapros, Tbk reported a annual operating expenses of 429.44 Billion IDR in annual operating expenses 2021, down -0.98% from previous year.
PT Phapros, Tbk reported a quarterly operating expenses of 104.77 Billion IDR for 2024 Q3, up 1.16% from previous quarter.
PT Phapros, Tbk reported a quarterly operating expenses of 92.16 Billion IDR for 2024 Q1, down -5.13% from previous quarter.

Annual Operating Expenses Chart of PT Phapros, Tbk (2023 - 2011)

Historical Annual Operating Expenses of PT Phapros, Tbk (2023 - 2011)

Year	Operating Expenses	Operating Expenses Growth
2023	428.44 Billion IDR	-4.63%
2022	489.78 Billion IDR	14.05%
2021	429.44 Billion IDR	-0.98%
2020	433.69 Billion IDR	-1.1%
2019	438.5 Billion IDR	12.63%
2018	389.31 Billion IDR	3.04%
2017	377.83 Billion IDR	15.54%
2016	327.01 Billion IDR	10.63%
2015	295.59 Billion IDR	12.66%
2014	262.38 Billion IDR	2.76%
2013	255.33 Billion IDR	7.92%
2012	236.58 Billion IDR	17.05%
2011	202.12 Billion IDR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	103.57 Billion IDR	12.39%
2024 Q3	104.77 Billion IDR	1.16%
2024 Q1	92.16 Billion IDR	-5.13%
2023 Q3	116.7 Billion IDR	-5.15%
2023 Q2	123.04 Billion IDR	6.21%
2023 Q1	115.85 Billion IDR	-6.84%
2023 Q4	97.14 Billion IDR	-16.76%
2023 FY	467.12 Billion IDR	-4.63%
2022 FY	489.78 Billion IDR	14.05%
2022 Q3	131.84 Billion IDR	13.25%
2022 Q2	116.41 Billion IDR	-0.63%
2022 Q1	117.15 Billion IDR	2.62%
2022 Q4	124.36 Billion IDR	-5.67%
2021 Q1	85.86 Billion IDR	-33.55%
2021 FY	429.44 Billion IDR	-0.98%
2021 Q4	114.16 Billion IDR	-11.85%
2021 Q3	129.5 Billion IDR	29.63%
2021 Q2	99.9 Billion IDR	16.35%
2020 Q4	129.21 Billion IDR	7.83%
2020 FY	433.69 Billion IDR	-1.1%
2020 Q1	92.24 Billion IDR	-25.9%
2020 Q2	92.39 Billion IDR	0.16%
2020 Q3	119.83 Billion IDR	29.71%
2019 Q3	105.99 Billion IDR	-15.9%
2019 Q4	124.48 Billion IDR	17.44%
2019 FY	438.5 Billion IDR	12.63%
2019 Q2	126.02 Billion IDR	53.7%
2019 Q1	81.99 Billion IDR	-30.49%
2018 Q4	117.96 Billion IDR	3.14%
2018 Q1	68.64 Billion IDR	-38.66%
2018 Q2	88.33 Billion IDR	28.69%
2018 FY	389.31 Billion IDR	3.04%
2018 Q3	114.37 Billion IDR	29.48%
2017 Q4	111.9 Billion IDR	0.0%
2017 FY	377.83 Billion IDR	15.54%
2016 FY	327.01 Billion IDR	10.63%
2015 FY	295.59 Billion IDR	12.66%
2014 FY	262.38 Billion IDR	2.76%
2013 FY	255.33 Billion IDR	7.92%
2012 FY	236.58 Billion IDR	17.05%
2011 FY	202.12 Billion IDR	0.0%

Peer Operating Expenses Comparison of PT Phapros, Tbk

Name	Operating Expenses	Operating Expenses Difference
PT Darya-Varia Laboratoria Tbk	762.07 Billion IDR	43.779%
PT Merck Tbk	200.74 Billion IDR	-113.43%
PT Pyridam Farma Tbk	293.43 Billion IDR	-46.01%
PT Industri Jamu dan Farmasi Sido Muncul Tbk	827.82 Billion IDR	48.244%
PT Tempo Scan Pacific Tbk	3255.8 Billion IDR	86.841%